Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Net Income towards Common Stockholders: 2017-2024

Historic Net Income towards Common Stockholders for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to -$169.0 million.

  • Bicycle Therapeutics' Net Income towards Common Stockholders fell 16.33% to -$59.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$250.7 million, marking a year-over-year decrease of 50.75%. This contributed to the annual value of -$169.0 million for FY2024, which is 6.44% up from last year.
  • According to the latest figures from FY2024, Bicycle Therapeutics' Net Income towards Common Stockholders is -$169.0 million, which was up 6.44% from -$180.7 million recorded in FY2023.
  • Over the past 5 years, Bicycle Therapeutics' Net Income towards Common Stockholders peaked at -$51.0 million during FY2020, and registered a low of -$180.7 million during FY2023.
  • In the last 3 years, Bicycle Therapeutics' Net Income towards Common Stockholders had a median value of -$169.0 million in 2024 and averaged -$154.1 million.
  • In the last 5 years, Bicycle Therapeutics' Net Income towards Common Stockholders plummeted by 68.69% in 2022 and then grew by 6.44% in 2024.
  • Over the past 5 years, Bicycle Therapeutics' Net Income towards Common Stockholders (Yearly) stood at -$51.0 million in 2020, then plummeted by 30.99% to -$66.8 million in 2021, then tumbled by 68.69% to -$112.7 million in 2022, then crashed by 60.28% to -$180.7 million in 2023, then increased by 6.44% to -$169.0 million in 2024.